Details for New Drug Application (NDA): 209324
✉ Email this page to a colleague
The generic ingredient in BOSENTAN is bosentan. There are nineteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bosentan profile page.
Suppliers and Packaging for NDA: 209324
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BOSENTAN | bosentan | TABLET;ORAL | 209324 | ANDA | Sun Pharmaceutical Industries, Inc. | 47335-038 | 47335-038-64 | 10 BLISTER PACK in 1 CARTON (47335-038-64) / 3 TABLET, FILM COATED in 1 BLISTER PACK (47335-038-60) |
BOSENTAN | bosentan | TABLET;ORAL | 209324 | ANDA | Sun Pharmaceutical Industries, Inc. | 47335-038 | 47335-038-86 | 60 TABLET, FILM COATED in 1 BOTTLE (47335-038-86) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 62.5MG | ||||
Approval Date: | Apr 26, 2019 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 125MG | ||||
Approval Date: | Apr 26, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription